Morning Breakouts

Latest KFF Health News Stories

Health Lobbying Means Cash Infusion For Candidates, TV Stations

Morning Briefing

“Health care groups working feverishly to shape — or kill — an industry-wide reform bill are lavishing campaign cash on the politicians at the center of the debate,” the Salt Lake Tribune reports.

Massachusetts Lawmakers Seek To Expand Insurance Services

Morning Briefing

“Massachusetts legislators this year have filed a flurry of bills – more than 70 in all – that, if passed, would substantially expand the medical services insurers are required to cover for patients but also potentially raise healthcare costs,” The Boston Globe reports.

PBS’ Online NewsHour, Lancet Examine Counterfeit Malaria Drugs In Cambodia

Morning Briefing

PBS’ Online NewsHour examines how “poor-quality and counterfeit malaria drugs” in Cambodia is contributing to a “growing resistance to treatment for the disease near the Thai-Cambodian border.”

Health Industry Spends $1.4 Million A Day On Lobbying

Morning Briefing

“In a new report released today, the government watchdog group Common Cause found that major health care interests have spent upwards of $1.4 million a day to lobby Capitol Hill so far this year.,” the National Journal reports.

Few Health Insurers Dominate Around America, Band Against Public Plan

Morning Briefing

Because most regions of the United States have only one or two major insurers, the groups are finding it easier to band together to rise up against Congressional proposals, such as the one to create a public plan, Business Week reports.

House Democrats Renew Threats To Bypass Energy Committee On Reform

Morning Briefing

Energy and Commerce Committee Chairman Henry Waxman has threatened to bypass his own committee and force a floor vote on health reform over an impasse and break in the Democratic ranks, The Associated Press reports.

Needle Exchange Programs Needed To Prevent Spread Of HIV, Letter To The Editor Says

Morning Briefing

“Despite making strides in addressing HIV/AIDS, we have not reached all individuals and communities with the full range of prevention tools needed to reverse the epidemic,” Jirair Ratevosian, chair of the American Public Health Association International Health Section’s Advocacy and Policy Committee, writes in a Washington Post letter to the editor.